Halozyme Therapeutics - 株価

HALO

51.45

毎日の変更:

8.98%

毎年:

147.36%

価格 日 年
Acadia Pharmaceuticals 48.69 -1.05 -2.11% 19.72%
Agios Pharmaceuticals 52.89 -1.28 -2.36% 13.23%
Alnylam Pharmaceuticals 151.59 -1.62 -1.06% 27.08%
Amgen 229.99 -2.47 -1.06% 9.32%
Amarin 7.30 0.07 0.97% -58.29%
Aptinyx Inc 3.80 0.09 2.43% 11.76%
Arena Pharmaceuticals 80.10 3.54 4.62% 67.61%
Baxter International 78.51 0.37 0.47% -9.75%
Cara Therapeutics 19.82 0.13 0.66% 23.95%
Cytokinetics 20.75 0.49 2.42% 40.96%
DBV Technologies 5.56 0.12 2.21% -40.98%
Esperion Therapeutics 28.55 0.67 2.40% -52.35%
Five Prime Therapeutics 25.71 2.28 9.73% 427.93%
Halozyme Therapeutics 51.45 4.24 8.98% 147.36%
Intercept Pharmaceuticals 28.60 0.48 1.71% -66.23%
Immunogen 9.13 -0.04 -0.44% 91.00%
Ionis Pharmaceuticals 56.21 0.16 0.29% 1.83%
Intra Cellular Therapies 37.84 0.95 2.58% 64.38%
Jazz Pharmaceuticals 173.50 16.03 10.18% 56.81%
Eli Lilly 204.52 2.04 1.01% 51.04%
MannKind 5.98 0.70 13.26% 342.96%
Minerva Neurosciences 3.42 0.10 3.01% -56.65%
Nektar Therapeutics 22.77 0.24 1.07% 2.80%
Pfizer 33.75 -0.16 -0.47% -0.53%
Peregrine Pharmaceuticals 18.60 0.71 3.97% 177.61%
Rigel Pharmaceuticals 4.37 0.29 7.11% 103.26%
United Therapeutics 173.70 1.32 0.77% 53.91%
Vanda Pharmaceuticals 20.28 1.59 8.51% 76.81%
Intrexon 8.57 0.30 3.63% 166.98%

価格 日 年
NASDAQ 13597 132.77 0.99% 51.67%
Russell 2000 2284 53.07 2.38% 45.33%

HALO:US
資産
現金と同等
売上原価
流動資産
流動負債
負債
EBIT
EBITDA
株当たりのEPS利益
自己資本および準備金
売上総利益
債務の支払利息
借入資本
時価総額
当期純利益
営業経費
営業利益
普通株資本
収益へのPE価格
税引前利益
販売収入
販売および管理費
株式
貿易債権者
貿易債務者